Steve Fruchtman | President, Chief Executive Officer |
Ric Woodman | Chief Medical Officer |
Mark Guerin | Chief Financial Officer |
Avi Oler | Vice President, Corporate Development, General Counsel |
Joe Pantginis | HC Wainwright |
Naureen Quibria | Maxim Group |
Yale Jen | Laidlaw & Company |
Ahu Demir | Noble Life Sciences |
Good morning ladies and gentlemen and welcome to Onconova Therapeutics corporate update and year-end 2018 financial results conference call. At this time, all participants are on a listen-only mode.
Following management’s remarks, I will open the call up for your questions. At this time, I’d like to turn the call over to Avi Oler, Vice President of Corporate Development and General Counsel at Onconova.
Thank you, Operator.